TNFRSF4 and neoplasm: OX40 signaling can attenuate Treg-mediated immunosuppression and reconfigure the functional patterns of B cells, dendritic cells, tumor-associated macrophages, and natural killer cells, thereby inhibiting tumor progression (9–12).